Trade Summary

3 days ago, Troendle August J., serving as President & CEO at Medpace Holdings, Inc. (MEDP), sold 42,783 shares at $614.30 per share, for a total transaction value of $26,281,389.69. Following this transaction, Troendle August J. now holds 561,195 shares of MEDP.

This sale represents a 7.08% decrease in Troendle August J.'s stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Wednesday, August 19, 2026 and publicly disclosed via SEC Form 4 filing on Friday, August 21, 2026 at 4:13 PM ET, 2 days after the trade was made.

Medpace Holdings, Inc. operates in the HEALTHCARE sector, specifically within the DIAGNOSTICS & RESEARCH industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.